US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

35.93

-1.9783-5.22%

Post-market: 34.80-1.1315-3.15%16:10 EDT

Volume:606

Turnover:21.23K

Market Cap:2.69M

PE:- -

High:35.93

Open:34.74

Low:34.74

Close:37.91

52wk High:45.88

52wk Low:25.71

Shares:75.00K

Float Shares:75.00K

Volume Ratio:0.64

T/O Rate:0.81%

Dividend:0.76

Dividend Rate:2.13%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Health Rounds: Genetic Discovery Yields Clues Toward Reversal of Alzheimer's Brain Damage

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Moderna Inc. Stock Advances 7.0%, Outperforms Peers

Regeneron to Report Q3 Results, Host Conference Call and Webcast

Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026

Regeneron Approaching Incremental Catalysts Like Upcoming Olatorepatide Data Readout, RBC Says

MT Newswires Live

Insmed resumed with a Buy at Goldman Sachs

Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong

Leerink Partners Remains a Hold on Amgen (AMGN)

Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches

US Judge Steps Aside in Dispute over Hawaii Energy Settlement

Stoke Therapeutics Names Solid Biosciences CEO Bo Cumbo to Board

Amgen Stock Forecast: AMGN Reclaims $410 as Pipeline Catalysts Build

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)

2026 Ranking of Top 500 Chinese Manufacturing Private Firms Released, Two Heilongjiang Companies Make the List

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)

Sensorion doubles down on GJB2 gene therapy as SENS-601 enters Phase I/II

These 'Moonshot' Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right.

Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $640 from $633

THOMSON REUTERS

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TBXU/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":35.9315,"timestamp":1791489600000,"preClose":37.9098,"halted":0,"volume":606,"hourTrading":{"tag":"盘后","latestPrice":34.8,"preClose":35.9315,"latestTime":"16:10 EDT","volume":7,"amount":250.6575,"timestamp":1791490204511,"change":-1.1315,"changeRate":-0.03149,"amplitude":0},"delay":0,"changeRate":-0.05218439559164115,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"Not Yet Opened","change":-1.9783,"latestTime":"10-08 16:00:00 EDT","open":34.74,"high":35.9315,"low":34.74,"amount":21229,"amplitude":0.03143,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":37.9098,"sharesOutstanding":100001,"nav":37.898,"aum":2842383.83,"dividendRate":0.021277,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.8,"preClose":35.9315,"latestTime":"16:10 EDT","volume":7,"amount":250.6575,"timestamp":1791490204511,"change":-1.1315,"changeRate":-0.03149,"amplitude":0},"volumeRatio":0.640998},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.640998,"shares":75001,"dividePrice":0.76452,"high":35.9315,"amplitude":0.03143,"preClose":37.9098,"low":34.74,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":35.9315,"eps":0,"divideRate":0.021277,"volume":606,"delay":0,"ttmEps":0,"open":34.74,"prevYearClose":31.065,"prevWeekClose":36.95,"prevMonthClose":39.9,"prevQuarterClose":39.9,"fiveDayClose":37.9097,"twentyDayClose":38.8987,"sixtyDayClose":31.7049},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-09-22","symbol":"TBXU","amount":0.14204,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-22","defaultRemindTime":1790083800000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-29","payableDate":"2026-09-22","currency":"USD","dateTimestamp":1790049600000,"payDate":"2026-09-29"},{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"},{"executeDate":"2026-09-22","recordDate":"2026-09-22","paymentDate":"2026-09-29","value":0.14204,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670413895","title":"Health Rounds: Genetic Discovery Yields Clues Toward Reversal of Alzheimer's Brain Damage","url":"https://stock-news.laohu8.com/highlight/detail?id=2670413895","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670413895?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:50","pubTimestamp":1790283042,"startTime":"0","endTime":"0","summary":"Health Rounds: Genetic discovery yields clues toward reversal of Alzheimer's brain damageSept 24 -Hello Health Rounds readers!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL1N45G0ZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","IE00B19Z3581.USD","LU1585245621.USD","BK4139","TMED","LU0882574055.USD","LU0289739699.SGD","LU1934455277.USD","LU2357627491.SGD","BBH","BK4588","LU1934455194.USD","BK4568","GILD","LU1023059063.AUD","IE0002270589.USD","SG9999015952.SGD","BK4585","LU0122379950.USD","MEDI","LU2087621335.USD","LU0965509010.AUD","IBB","BK4578","LU0114720955.EUR","LU1037948541.HKD","BK4550","BIB","LU0234570918.USD","BK4583","LU0823416689.USD","IE00B7SZLL34.SGD","TBXU","IBBQ","LU0965509101.SGD","LU1934455863.HKD","LU0058720904.USD","IE00BSNM7G36.USD","LU1674673428.USD","LU1061106388.HKD","LU0320765992.SGD","LU0861579265.USD","LU2324357040.USD","LU2089984988.USD","SG9999015945.SGD","SG9999015978.USD","LU1037948897.HKD","IE00B19Z3B42.SGD","BK4532","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670180864","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670180864","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670180864?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:35","pubTimestamp":1790282100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 1.11% to $149.69 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,704.13 and Dow Jones Industrial Average  falling 0.31% to 51,349.98.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 4.83% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 0.56% to $270.68, Pfizer Inc.  rose 0.82% to $28.41, and Abbott Laboratories  fell 2.34% to $101.07.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU0058720904.USD","LU1037948897.HKD","LU1066051498.USD","LU2357627491.SGD","BBH","LU0109394709.USD","LU0234570918.USD","SG9999015986.USD","IE00BKVL7J92.USD","LU1037948541.HKD","TMED","LU0965509283.SGD","BK4566","BK4550","IE0002270589.USD","LU0965509010.AUD","LU1934455277.USD","LU1057294990.SGD","LU0122379950.USD","LU0823416689.USD","LU0889565916.HKD","LU1839511570.USD","SG9999015978.USD","LU1934455194.USD","LU2324357040.USD","LU2112291526.USD","IE00BSNM7G36.USD","LU2089984988.USD","LU1066053197.SGD","BK4588","IE00B3T34201.USD","SG9999015945.SGD","IBB","IE00B7SZLL34.SGD","BK4585","LU0965508806.USD","IE00B19Z3B42.SGD","BK4139","LU2087621335.USD","TBXU","IBBQ","IE00BZ1G4Q59.USD","LU0289739699.SGD","LU1674673691.USD","LU1934455863.HKD","BK4532","LU0859254822.USD","MEDI","LU1585245621.USD","BK4568","BMED","LU1571399168.USD","BK4583","LU1778281490.HKD","LU1430594728.SGD","LU0861579265.USD","LU2468319806.SGD","SG9999015952.SGD","LU0882574055.USD","LU0320765992.SGD","BK4578","LU0965509101.SGD","BIB","LU1023059063.AUD","IE00B19Z3581.USD","GILD","LU1674673428.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670184794","title":"Moderna Inc. Stock Advances 7.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2670184794","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670184794?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:33","pubTimestamp":1790281980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 7.0% to $194.82 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 26,939.37 and the Dow Jones Industrial Average falling 0.3% to 51,349.98.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $192.31, which the company reached on September 23rd.The stock outperformed some of its peers, as Johnson & Johnson rose 0.6% to $270.68, Pfizer Inc. rose 0.8% to $28.41, and Gilead Sciences Inc. fell 1.11% to $149.69.Trading volume totaled 16.4 million, compared to the 50-day average of 18.6 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU1066053197.SGD","IE0002270589.USD","MEDI","SG9999015952.SGD","LU0965509283.SGD","LU2357627491.SGD","TBXU","TMED","BK4550","BK4534","LU2468319806.SGD","BMED","LU1066051498.USD","IBBQ","IE00BZ1G4Q59.USD","LU0289739699.SGD","LGHT","IDNA","LU0965509101.SGD","LU0965509010.AUD","GNOM","BK4568","MRNY","IE00B3T34201.USD","LU0859254822.USD","LU1057294990.SGD","LU0861579265.USD","LU1934455863.HKD","LU1674673428.USD","LU2324357040.USD","LU1571399168.USD","WDNA","BIB","GILD","BK4551","IE00B19Z3581.USD","LU0234570918.USD","BK4532","MRNX","LU1061106388.HKD","IBB","LU2112291526.USD","BBH","MRNA","LU0965508806.USD","LU1778281490.HKD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670541882","title":"Regeneron to Report Q3 Results, Host Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2670541882","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670541882?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:06","pubTimestamp":1790280375,"startTime":"0","endTime":"0","summary":"Regeneron to report Q3 results, host conference call and webcastRegeneron schedules third-quarter 2026 financial results for Oct. 30, 2026, before the U.S. market open.Conference call, webcast set for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL85Bt96:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE00BN0W2W23.USD","LU2468319806.SGD","BK4112","LU2210149790.SGD","REGN","IE00BKPKM429.USD","BBH","IE00BQXX3D17.EUR","LU2023250504.SGD","LU0320765992.SGD","NDAQ","IE00BGHQF748.EUR","LU2237438978.USD","LU0314104364.USD","BK4585","LU0823416689.USD","LU1974910355.USD","LU2210150020.SGD","IBB","LU0289739699.SGD","IBBQ","TBXU","LU2362540622.SGD","LU2089984988.USD","SG9999014021.USD","IE00BQXX3F31.USD","LU0053666078.USD","LU0058720904.USD","LU2362541273.HKD","IE00BN0W2T93.GBP","LU0823434583.USD","LU2095319765.USD","LU0109394709.USD","SG9999014013.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","LU2362541513.USD","BK4588","LU0823434740.USD","LU1917777945.USD","IE00BN0W2V16.EUR","LU2106854487.HKD","SG9999014039.USD","IE00B3QW5Z07.USD","BK4139","LU0882574055.USD","BCDF","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670183654","title":"Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670183654","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670183654?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:05","pubTimestamp":1790280300,"startTime":"0","endTime":"0","summary":"TARRYTOWN, N.Y., Sept.  24, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third quarter 2026 financial and operating results on Friday","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368733/0/en/regeneron-to-report-third-quarter-2026-financial-and-operating-results-and-host-conference-call-and-webcast-on-october-30-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BBH","LU1974910355.USD","LU2362541273.HKD","BK4588","LU0114720955.EUR","LU2023250504.SGD","LU0823434740.USD","REGN","LU0823416689.USD","LU2468319806.SGD","LU0109394709.USD","LU0882574055.USD","LU1917777945.USD","IBB","LU2237438978.USD","BK4139","BK4585","TBXU","LU0053666078.USD","IBBQ","LU2089984988.USD","LU0889565916.HKD","LU2362541513.USD","LU0320765992.SGD","LU0823434583.USD","LU2106854487.HKD","LU2362540622.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669043491","title":"Regeneron Approaching Incremental Catalysts Like Upcoming Olatorepatide Data Readout, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669043491","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669043491?lang=en_us&edition=fundamental","pubTime":"2026-09-24 23:29","pubTimestamp":1790263782,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  is approaching a series of incremental catalysts, including the data readout from the phase 3 China study of olatorepatide next week, RBC Capital Markets said in a Thursday note.RBC said topline efficacy data on olatorepatide, the company's weight-management product candidate, has been generally announced, with up to a 19% mean weight loss at week 48. Focus would be on the safety of therapy at the 15-milligram dose, the brokerage noted.Late-breaking abstract data indicate the 15-milligram dose as the best option to proceed with, versus other evaluated doses, based on efficacy, though safety details remain pending, RBC said. Olatorepatide's initial safety profile seem \"more benign\" compared with tirzepatide, but the China data could bring more reassurance to investors, the investment firm added.RBC maintained its sector perform rating on Regeneron Pharmaceuticals, with a $737 price target.Price: 799.53, Change: -2.29, Percent Change: -0.29","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBH","LU0823416689.USD","LU0889565916.HKD","LU2023250504.SGD","TBXU","REGN","BK4588","LU2362541513.USD","LU0114720955.EUR","LU2106854487.HKD","LU1917777945.USD","LU0882574055.USD","LU0823434740.USD","BK4139","LU0053666078.USD","LU2362540622.SGD","LU0823434583.USD","IBB","LU2089984988.USD","LU0058720904.USD","LU0320765992.SGD","IBBQ","LU1974910355.USD","LU2468319806.SGD","LU2362541273.HKD","LU2237438978.USD","LU0289739699.SGD","BK4585","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669656404","title":"Insmed resumed with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669656404","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669656404?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:45","pubTimestamp":1790239509,"startTime":"0","endTime":"0","summary":"Goldman Sachs resumed coverage of Insmed (INSM) with a Buy rating and $188 price target Goldman resumed coverage of the biotechnology sector, sayin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/insmed-resumed-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/insmed-resumed-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0106831901.USD","LU1868837300.USD","LU2471134523.USD","FHLC","BK4585","APXH","LU2471134796.USD","NFEB","XLK","FWD","LU1868837136.USD","BK4588","LU0053671581.USD","LU1868836757.USD","BK4533","INSM","BBP","IEIH","RSPH","LU2896262040.SGD","TBXU","LU0320765992.SGD","BIOY","LU0061475181.USD","LU0868494708.USD","LU2237443549.SGD","LU2265009873.SGD","IE00B19Z3581.USD","IBB","LU1804176565.USD","LU1894683264.USD","LU2750360997.AUD","LU2237443895.HKD","DARP","LNGR","JDOC","LU2237443465.HKD","GSX","XT","IE0004086264.USD","RKSG","XLSR","KQQQ","IGM","LU2237443978.SGD","AGNG","WDNA","LU0109394709.USD","BK4552","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669463318","title":"Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2669463318","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669463318?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:31","pubTimestamp":1790238660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.8% to 5.59 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.3% to 24761.13.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 35% below its 52-week high of HK$8.54, which the company reached Oct. 8.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 3.2% and Amgen Inc. remained unchanged.Trading volume totaled 52.8 million shares, compared to the 50-day average of 85.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU0889565916.HKD","BK1191","LU0058720904.USD","BK4566","LU2242646821.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0109394709.USD","IBB","IE00BZ08YR35.GBP","SG9999001440.SGD","BK4139","AMGN","BK4581","LU1023059063.AUD","IE0002141913.USD","01177","IE00BJT1NW94.SGD","LU2468319806.SGD","LU2112291526.USD","TBXU","BK4533","LU0868494617.USD","LU2089984988.USD","LU1571399168.USD","IBBQ","BK1589","LU0122379950.USD","BIB","IE00BFTCPJ56.SGD","BK4534","BK1515","BK4599","LU0289739699.SGD","IE0009355771.USD","PJP","BK4588","IE00B2B36J28.USD","LU1061106388.HKD","PBE","IE00BZ08YT58.USD","BBH","BK4585","LU1057294990.SGD","LU2242652126.USD","IE00BZ08YS42.EUR","LU1983299246.USD","BK1521","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669381451","title":"Leerink Partners Remains a Hold on Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669381451","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669381451?lang=en_us&edition=fundamental","pubTime":"2026-09-24 13:15","pubTimestamp":1790226924,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from Leerink Partners maintained a Hold rating on Amgen. The company’s shares closed yesterday at $406.09. In addit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-hold-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-hold-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","LU0320765992.SGD","LU2468319806.SGD","LU1571399168.USD","BK4585","IE00BFTCPJ56.SGD","LU1023059063.AUD","BK4534","IBB","LU1057294990.SGD","BIB","IBBQ","LU2242652126.USD","LU2112291526.USD","LU1983299246.USD","AMGN","BBH","IE00B4R5TH58.HKD","LU0889565916.HKD","IE0002141913.USD","BK4599","BK4581","LU0868494617.USD","LU0122379950.USD","IE00B2B36J28.USD","TBXU","LU0058720904.USD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU0109394709.USD","IE0009355771.USD","BK4139","IE00BJT1NW94.SGD","LU2242646821.SGD","BK4533","LU1061106388.HKD","BK4588","SG9999001440.SGD","PJP","PBE","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669437128","title":"Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches","url":"https://stock-news.laohu8.com/highlight/detail?id=2669437128","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669437128?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:30","pubTimestamp":1790209807,"startTime":"0","endTime":"0","summary":"An announcement from Mesoblast Limited ( ($AU:MSB) ) is now available. Mesoblast has secured U.S. FDA approval for a new T-cell Proliferation Inhib...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LABU","NVIB","IDNA","BK4139","LFSC","MEDI","MRNY","GNMX","RSPH","IEIH","MESO","FRTY","MRNX","GDOC","TBXU","XLVX","BBP","BK4588","PSCH","PINK","SYNB","IYH","BK4585","BMED","TECB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669843952","title":"US Judge Steps Aside in Dispute over Hawaii Energy Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669843952","media":"Reuters","labels":["policyRegulatory","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669843952?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:00","pubTimestamp":1790197259,"startTime":"0","endTime":"0","summary":"US judge steps aside in dispute over Hawaii energy settlementSept 23 (Reuters)-A federal judge in Hawaii has disqualified himself from hearing a dispute over whether a decades-old price-fixing settlem","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL6N45F14Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVX","XLE","TEXU","LU0456854461.SGD","LU2129689605.HKD","LU0098860793.USD","WEEI","SG9999002521.SGD","FTXN","LU1037948541.HKD","LU0868494708.USD","BK4559","DRLL","DIG","BIB","LU2468319806.SGD","LU0861579265.USD","IBB","GXPE","LU0122376428.USD","BK4588","LU0162691827.USD","LU0265550946.USD","FENY","LU0942090050.USD","BK4201","GILD","TRUN","IE0002270589.USD","BBH","MEDI","LU0300736062.USD","LU0640476718.USD","LU0265550359.USD","ERX","LU0965509010.AUD","LU0149725797.USD","IE00B3T34201.USD","LU1929549753.HKD","TBXU","IGE","IYE","VDE","IBBQ","TMED","LU0234570918.USD","BMED","IE00B19Z3B42.SGD","LU0256863811.USD","IXC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669090435","title":"Stoke Therapeutics Names Solid Biosciences CEO Bo Cumbo to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2669090435","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669090435?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:01","pubTimestamp":1790193684,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics names Solid Biosciences CEO Bo Cumbo to boardStoke Therapeutics appointed Bo Cumbo to its board.Edward Kaye retired as a director; he served on the board since 2017 and was CEO from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL9kWWfM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU0889565916.HKD","LU1066053197.SGD","LU1674673691.USD","BMED","LU1023059063.AUD","BK4139","STOK","LU0122379950.USD","LU2324357040.USD","MEDI","IE0002141913.USD","LU0859254822.USD","LU2468319806.SGD","SRPU","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU2087621335.USD","LU0882574055.USD","LU1037948541.HKD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","LU2112291526.USD","IE00BZ1G4Q59.USD","BK4578","IE0002270589.USD","SLDB","TMED","LU1061106388.HKD","IE00B2B36J28.USD","BK4550","GILD","LU1778281490.HKD","SRPT","BK4588","IE0009355771.USD","LU1934455277.USD","LU0320765992.SGD","LU1934455194.USD","IE00B19Z3581.USD","BBH","IBBQ","LU1674673428.USD","IE00BKVL7J92.USD","LU0109394709.USD","IBB","BK4585","TBXU","IE00BJT1NW94.SGD","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669646482","title":"Amgen Stock Forecast: AMGN Reclaims $410 as Pipeline Catalysts Build","url":"https://stock-news.laohu8.com/highlight/detail?id=2669646482","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669646482?lang=en_us&edition=fundamental","pubTime":"2026-09-23 23:00","pubTimestamp":1790175600,"startTime":"0","endTime":"0","summary":"Amgen rebounds to $410.24 as dazodalibep and IMDELLTRA strengthen the pipeline while $418.73 becomes the next technical test.\n","market":"nz","thumbnail":"https://resource.tradingkey.com/uploads/20260923/AMGEN-82b57eea98fd4d6fa458e68c35b3ab95.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260923/AMGEN-82b57eea98fd4d6fa458e68c35b3ab95.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262182585-stocks-amgen-stock-forecast-pipeline-410-breakout-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGSX","LU0868494617.USD","AZN","TSDD","AZNH","CRSH","TSLI","TSL","ORR","TSLZ","PJP","TSYY","TSLO","ORR.AU","BIB","TEST","LU1061106388.HKD","TSLG","TLA","PFS","TBXU","07366","IE0009355771.USD","LU1571399168.USD","LU2242652126.USD","AMGN","07766","IBB","IE0002141913.USD","LU1983299246.USD","LU2468319806.SGD","TSLS","BBH","TESL","09766","TESC","ELOL","TSII","TSLP","BK7095","TSLW","TSLQ","TSLT","TSLL","PBE","IBBQ","TSLY","LU2237443549.SGD","TSLR","09366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669648508","title":"Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669648508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669648508?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:30","pubTimestamp":1790166641,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nek...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU1069344957.HKD","IE00BJJMRZ35.SGD","NKTR","IDNA","VRTX","BIB","LABU","IE00B894F039.SGD","GNMX","IE00BZ9MQY76.HKD","LU2362541273.HKD","BK4007","XLV","IE00B19Z3581.USD","BBH","LU0109394709.USD","LU2362541513.USD","LU2089984988.USD","LU0256863811.USD","LU0289739699.SGD","LU0823416689.USD","XBI","LU2324357040.USD","SG9999001176.SGD","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","LU2237438978.USD","KYMR","VERX","LU0061475181.USD","LU0432979614.USD","BK4585","LU1559883803.SGD","LU0234570918.USD","LU0417517546.SGD","BK4023","IBB","BK4533","IE0002141913.USD","BK4139","SG9999001176.USD","TBXU","LU2417539215.USD","HCSG","LU0757428866.USD","LU1035775433.USD","IBBQ","IE0002270589.USD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140458500","title":"2026 Ranking of Top 500 Chinese Manufacturing Private Firms Released, Two Heilongjiang Companies Make the List","url":"https://stock-news.laohu8.com/highlight/detail?id=1140458500","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140458500?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:21","pubTimestamp":1790166086,"startTime":"0","endTime":"0","summary":"On September 22, the All-China Federation of Industry and Commerce released the \"2026 China Manufacturing Top 500 Private Enterprises\" list, with two enterprises from Heilongjiang province securing...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1597","BK1500","06186","BK1553","BK1589","BK1237","TBXU","BIOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669711101","title":"Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669711101","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669711101?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:10","pubTimestamp":1790154626,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Quest Diagnostics (DGX), AnaptysBio (ANAB) and Verte...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1585245621.USD","BK4139","IE00B2B36J28.USD","LU0757428866.USD","VERX","LU0823417653.USD","LU0289739699.SGD","SG9999001176.SGD","LABU","BBH","LU0109394709.USD","IE0002270589.USD","VRTX","LU0823417737.USD","LU0079474960.USD","LU2456880835.USD","XBI","GNMX","XLV","IBB","BIB","LU0234570918.USD","DGX","SG9999001176.USD","BK4583","LU0823416689.USD","TBXU","IBBQ","LU1815336091.USD","LU2462157665.USD","IDNA","LU0417517546.SGD","LU2506952097.USD","BK4567","IE0009355771.USD","IE00BZ9MQY76.HKD","ANAB","LU2506951875.HKD","IE00BJT1NW94.SGD","LU1093756325.SGD","SGXZ57979304.SGD","FFTY","HCSG","LU2089984988.USD","LU1854103824.USD","LU2506952170.USD","IE00BJJMRZ35.SGD","PBE","LU1035775433.USD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669108132","title":"Sensorion doubles down on GJB2 gene therapy as SENS-601 enters Phase I/II","url":"https://stock-news.laohu8.com/highlight/detail?id=2669108132","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669108132?lang=en_us&edition=fundamental","pubTime":"2026-09-23 14:24","pubTimestamp":1790144664,"startTime":"0","endTime":"0","summary":"An update from Sensorion SAS ( ($FR:ALSEN) ) is now available. Sensorion has sharpened its strategic focus on SENS-601, a single-vector AAV gene th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sensorion-doubles-down-on-gjb2-gene-therapy-as-sens-601-enters-phase-i-ii?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sensorion-doubles-down-on-gjb2-gene-therapy-as-sens-601-enters-phase-i-ii?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNOM","IBBQ","BK4082","TBXU","LFSC","SENS","IBB","CNCR","BK4588","SYNB","BK4585","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669177094","title":"These 'Moonshot' Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669177094","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669177094?lang=en_us&edition=fundamental","pubTime":"2026-09-23 13:45","pubTimestamp":1790142300,"startTime":"0","endTime":"0","summary":"From speculation over mergers and acquisitions to the hype surrounding clinical readouts, it seems biotechnology stocks are all the rage this year.The iShares Biotechnology exchange-traded fund has ri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWB","WDNA","LU2347655156.SGD","LU0210528500.USD","MRNX","LU0234570918.USD","LU1244550221.USD","BK4585","ARWR","BK4599","IDNA","LU2357305700.SGD","LGHT","MRNY","THNR","IBB","ARGX","MRNA","IAI","OZEM","BK4548","GNOM","LU1732800096.USD","VKTX","LU1791710582.SGD","IE00B4R5TH58.HKD","BK4501","BK4551","XBI","LU0795875169.SGD","LU1244550494.USD","LU1720051017.SGD","FMED","LU1074936037.SGD","IE00BKVL7J92.USD","BK4534","LU1988902786.USD","TBXU","BK4568","LU0109394709.USD","LU1548497426.USD","LU0158827948.USD","LU0098860793.USD","BK4532","MS","LU1989772840.SGD","LU0006306889.USD","BK4504","IE00B775SV38.USD","IE00B3S45H60.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669999174","title":"Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $640 from $633","url":"https://stock-news.laohu8.com/highlight/detail?id=2669999174","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669999174?lang=en_us&edition=fundamental","pubTime":"2026-09-23 11:36","pubTimestamp":1790134588,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45E0RF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","IE00B19Z3581.USD","LU1778281490.HKD","IE00BJT1NW94.SGD","IE00B894F039.SGD","BK4585","LU1035775433.USD","LU1069344957.HKD","LU0058720904.USD","LU0432979614.USD","LU0061475181.USD","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","SG9999001176.USD","LU2362541273.HKD","LU1674673428.USD","LU0234570918.USD","BK4139","IE00BZ9MQY76.HKD","LU2456880835.USD","SG9999013999.USD","LU1093756325.SGD","BBH","LU2462157665.USD","IE00B19Z3B42.SGD","TBXU","VRTX","IE00B19Z9Z06.USD","LU1585245621.USD","BK4588","LU0889565916.HKD","IE0002270589.USD","LU0320765992.SGD","PBE","IE0002141913.USD","LU2362540622.SGD","GNMX","BIB","IE00B19Z9P08.USD","LU0109394709.USD","IBB","LU2417539215.USD","BK4567","LU2237438978.USD","IE0009355771.USD","LU2468319806.SGD","LU1093756168.USD","IE00B4R5TH58.HKD","IDNA","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669171122","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2669171122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669171122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:34","pubTimestamp":1790109240,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.40% to $152.67 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  remaining mostly unchanged at 7,764.64 and the Dow Jones Industrial Average  falling 0.36% to 51,863.69.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 2.94% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 0.10% to $269.19, Pfizer Inc.  rose 0.68% to $27.93, and Abbott Laboratories  rose 0.69% to $103.69.Trading volume  remained 1.3 million below its 50-day average volume of 6.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU1585245621.USD","IE00B7SZLL34.SGD","BK4585","LU2324357040.USD","LU0289739699.SGD","IE00B3T34201.USD","LU0109394709.USD","LU1674673691.USD","LU0889565916.HKD","LU2087621335.USD","MEDI","LU0122379950.USD","LU1023059063.AUD","LU1934455194.USD","LU0823416689.USD","IE00B19Z3B42.SGD","LU2468319806.SGD","BBH","GILD","BK4588","LU1778281490.HKD","BK4583","LU0965509010.AUD","LU1037948541.HKD","IE00BSNM7G36.USD","LU0965508806.USD","LU2112291526.USD","TMED","LU0234570918.USD","BK4566","LU1061106388.HKD","BK4532","IE0002270589.USD","LU1934455863.HKD","BIB","BMED","LU1057294990.SGD","BK4550","TBXU","IBBQ","LU1839511570.USD","SG9999015952.SGD","IE00BZ1G4Q59.USD","LU1934455277.USD","LU0861579265.USD","LU2357627491.SGD","LU0058720904.USD","LU1037948897.HKD","SG9999015986.USD","LU1066053197.SGD","LU1571399168.USD","LU1674673428.USD","BK4568","LU1066051498.USD","BK4139","LU1430594728.SGD","SG9999015945.SGD","LU0882574055.USD","LU0965509283.SGD","IE00BKVL7J92.USD","LU0965509101.SGD","IBB","LU0859254822.USD","LU2089984988.USD","SG9999015978.USD","BK4578","IE00B19Z3581.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}